{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:18:37Z","timestamp":1785446317709,"version":"3.56.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010801","name":"Government of Galicia","doi-asserted-by":"publisher","award":["ED431C 2024\/09"],"award-info":[{"award-number":["ED431C 2024\/09"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2023-149544OB-C22"],"award-info":[{"award-number":["PID2023-149544OB-C22"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/S023054\/1"],"award-info":[{"award-number":["EP\/S023054\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejpb.2025.114798","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T02:35:48Z","timestamp":1750300548000},"page":"114798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Inkjet printing of pharmaceutical tattoos for the direct deposition of oestradiol onto skin in turner syndrome"],"prefix":"10.1016","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5717-6400","authenticated-orcid":false,"given":"Patricija","family":"Januskaite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Goyanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2047-5025","authenticated-orcid":false,"given":"Mine","family":"Orlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5368-6603","authenticated-orcid":false,"given":"Abdul W.","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114798_b0005","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1210\/jc.2006-0558","article-title":"Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome","volume":"91","author":"Stochholm","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejpb.2025.114798_b0010","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1210\/endo-23-5-566","article-title":"A syndrome of infantilism, congenital webbed neck, and cubitus valgus1","volume":"23","author":"Turner","year":"1938","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejpb.2025.114798_b0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/jcdd8110138","article-title":"A review of recent developments in turner syndrome research","volume":"8","author":"Huang","year":"2021","journal-title":"J. Cardiovasc. Dev. Disease"},{"key":"10.1016\/j.ejpb.2025.114798_b0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5582\/irdr.2017.01056","article-title":"A basic understanding of turner syndrome: incidence, complications, diagnosis, and treatment","volume":"7","author":"Cui","year":"2018","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.ejpb.2025.114798_b0025","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41574-019-0224-4","article-title":"Turner syndrome: mechanisms and management","volume":"15","author":"Gravholt","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejpb.2025.114798_b0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.31887\/DCNS.2009.11.3\/pmwise","article-title":"Estradiol: a hormone with diverse and contradictory neuroprotective actions","volume":"11","author":"Wise","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.ejpb.2025.114798_b0035","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1210\/jc.2017-02183","article-title":"Estrogen replacement in turner syndrome: literature review and practical considerations","volume":"103","author":"Klein","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejpb.2025.114798_b0040","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/bph.13059","article-title":"Transdermal patches: history, development and pharmacology","volume":"172","author":"Pastore","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114798_b0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1687-9856-2014-12","article-title":"A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism","volume":"2014","author":"Shah","year":"2014","journal-title":"Int. J. Pediatr. Endocrinol."},{"key":"10.1016\/j.ejpb.2025.114798_b0050","doi-asserted-by":"crossref","DOI":"10.4158\/EP161622.OR","article-title":"Oral versus transdermal estrogen in turner syndrome: a systematic review and meta-analysis","volume":"23","author":"Zaiem","year":"2017","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.ejpb.2025.114798_b0055","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1210\/jc.2011-1449","article-title":"Pharmacokinetics and pharmacodynamics of oral and transdermal 17\u03b2 estradiol in girls with Turner syndrome","volume":"96","author":"Taboada","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejpb.2025.114798_b0060","doi-asserted-by":"crossref","first-page":"e1040","DOI":"10.1210\/clinem\/dgad649","article-title":"Current recommended estrogen dosing for pubertal induction in turner syndrome results in normal uterine growth","volume":"109","author":"Lindsay Mart","year":"2024","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.ejpb.2025.114798_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2018.00023","article-title":"Late-onset puberty induction by transdermal estrogen in turner syndrome girls-a longitudinal study","volume":"9","author":"Gawlik","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ejpb.2025.114798_b0070","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0430","article-title":"Clinical practice guidelines for the care of girls and women with turner syndrome: proceedings from the 2016 cincinnati international turner syndrome meeting","volume":"177","author":"Gravholt","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ejpb.2025.114798_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1051695","article-title":"Pubertal induction in Turner syndrome without gonadal function: a possibility of earlier, lower-dose estrogen therapy","volume":"14","author":"Hasegawa","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejpb.2025.114798_b0080","first-page":"327","article-title":"Availability, usage, and preferences of estradiol and progestogen preparations for puberty induction from a multicentral perspective","volume":"98","author":"Gawlik-Starzyk","year":"2025","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ejpb.2025.114798_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/phar.1850","article-title":"Clonidine for sedation and analgesia and withdrawal in critically Ill infants and children","volume":"36","author":"Capino","year":"2016","journal-title":"Pharmacother.: J. Human Pharmacol. Drug Ther."},{"key":"10.1016\/j.ejpb.2025.114798_b0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2146\/ajhp110158","article-title":"Practical considerations for optimal transdermal drug delivery","volume":"69","author":"Durand","year":"2012","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ejpb.2025.114798_b0095","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1530\/EC-19-0025","article-title":"Estradiol matrix patches for pubertal induction: stability of cut pieces at different temperatures","volume":"8","author":"Ankarberg-Lindgren","year":"2019","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.ejpb.2025.114798_b0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000500050","article-title":"Optimal pubertal induction in girls with turner syndrome using either oral or transdermal estradiol: a proposed modern strategy","volume":"91","author":"Donaldson","year":"2019","journal-title":"Hormone Res. Paediatr."},{"key":"10.1016\/j.ejpb.2025.114798_b0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000356922","article-title":"Physiological estrogen replacement therapy for puberty induction in girls: a clinical observational study","volume":"81","author":"Ankarberg-Lindgren","year":"2014","journal-title":"Hormone Res. Paediatr."},{"key":"10.1016\/j.ejpb.2025.114798_b0110","first-page":"3039","article-title":"Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls1","volume":"86","author":"Ankarberg-Lindgren","year":"2001","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.ejpb.2025.114798_b0115","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1039\/C5LC00235D","article-title":"Inkjet printing for biosensor fabrication: combining chemistry and technology for advanced manufacturing","volume":"15","author":"Li","year":"2015","journal-title":"Lab Chip"},{"key":"10.1016\/j.ejpb.2025.114798_b0120","article-title":"Characterization and inkjet printing of an RNA aptamer for paper-based biosensing of ciprofloxacin","volume":"9","author":"Jaeger","year":"2019","journal-title":"Biosensors (Basel)"},{"key":"10.1016\/j.ejpb.2025.114798_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/nano11071645","article-title":"Fully inkjet-printed biosensors fabricated with a highly stable ink based on carbon nanotubes and enzyme-functionalized nanoparticles","volume":"11","author":"Mass","year":"2021","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.ejpb.2025.114798_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.113737","article-title":"A plug, print & play inkjet printing and impedance-based biosensing technology operating through a smartphone for clinical diagnostics","volume":"196","author":"Rosati","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.ejpb.2025.114798_b0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1021\/acs.molpharmaceut.5b00570","article-title":"Development and biological evaluation of inkjet printed drug coatings on intravascular stent","volume":"13","author":"Scoutaris","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114798_b0140","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/pharmaceutics14020448","article-title":"Printing drugs onto nails for effective treatment of onychomycosis","volume":"14","author":"Pollard","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114798_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/gels8070417","article-title":"Preparation of vancomycin-loaded aerogels implementing inkjet printing and superhydrophobic surfaces","volume":"8","author":"Remui\u00f1\u00e1n-Pose","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2025.114798_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010159","article-title":"Coupling of fused deposition modeling and inkjet printing to produce drug loaded 3D printed tablets","volume":"14","author":"Junqueira","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114798_b0155","article-title":"Inkjet drug printing onto contact lenses: Deposition optimisation and non-invasive dose verification","volume":"5","author":"Pollard","year":"2023","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.ejpb.2025.114798_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.06.034","article-title":"Track-and-trace: Novel anti-counterfeit measures for 3D printed personalized drug products using smart material inks","volume":"567","author":"Trenfield","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114798_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124005","article-title":"Customizable orodispersible films: Inkjet printing and data matrix encoding for personalized hydrocortisone dosing","volume":"655","author":"Rodr\u00edguez-Pombo","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114798_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120462","article-title":"Inkjet printing of small molecules, biologics, and nanoparticles","volume":"600","author":"Chou","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114798_b0175","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309164","article-title":"Inkjet printing of pharmaceuticals","volume":"36","author":"Carou-Senra","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejpb.2025.114798_b0180","article-title":"Predicting pharmaceutical inkjet printing outcomes using machine learning","volume":"5","author":"Carou-Senra","year":"2023","journal-title":"Int. J. Pharmaceut.: X"},{"key":"10.1016\/j.ejpb.2025.114798_b0185","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202105015","article-title":"Inkjet printing and 3D printing strategies for biosensing, analytical, and diagnostic applications","volume":"34","author":"Zub","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejpb.2025.114798_b0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jddst.2018.03.021","article-title":"Modulation of transdermal drug delivery with coated microneedles","volume":"45","author":"Ita","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114798_b0195","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13346-015-0251-1","article-title":"Inkjet printing of insulin microneedles for transdermal delivery","volume":"5","author":"Ross","year":"2015","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2025.114798_b0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mee.2017.02.018","article-title":"Accuracy and feasibility of piezoelectric inkjet coating technology for applications in microneedle-based transdermal delivery","volume":"172","author":"O'Mahony","year":"2017","journal-title":"Microelectron. Eng."},{"key":"10.1016\/j.ejpb.2025.114798_b0205","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ijpharm.2015.01.038","article-title":"Inkjet printing of transdermal microneedles for the delivery of anticancer agents","volume":"494","author":"Uddin","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114798_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110248","article-title":"3D printed microneedles for anticancer therapy of skin tumours","volume":"107","author":"Uddin","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.ejpb.2025.114798_b0215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/10837450.2019.1684520","article-title":"Preparation and characterization of indomethacin loaded films by piezoelectric inkjet printing: a personalized medication approach","volume":"25","author":"Arshad","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2025.114798_b0220","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/acsbiomaterials.7b00138","article-title":"Inkjet printing-based patchable multilayered biomolecule-containing nanofilms for biomedical applications","volume":"3","author":"Choi","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.ejpb.2025.114798_b0225","article-title":"Harnessing handheld inkjet printing technology for rapid and decentralised fabrication of drug-loaded hydroxypropyl cellulose buccal films","author":"Carou-Senra","year":"2025","journal-title":"Carbohydr. Polym. Technol. Appl."},{"key":"10.1016\/j.ejpb.2025.114798_b0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molimm.2014.10.023","article-title":"The immunology of the porcine skin and its value as a model for human skin","volume":"66","author":"Summerfield","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejpb.2025.114798_b0235","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1147\/rd.283.0322","article-title":"Numerical calculation of the fluid dynamics of drop-on-demand jets","volume":"28","author":"Fromm","year":"1984","journal-title":"IBM J. Res. Dev."},{"key":"10.1016\/j.ejpb.2025.114798_b0240","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1021\/la900059m","article-title":"Influence of fluid physical properties on ink-jet printability","volume":"25","author":"Jang","year":"2009","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2025.114798_b0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00403-019-02017-5","article-title":"Effect of propylene glycol on the skin penetration of drugs","volume":"312","author":"Carrer","year":"2020","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.ejpb.2025.114798_b0250","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1021\/acs.jpcb.3c06784","article-title":"Mechanisms of the drug penetration enhancer propylene glycol interacting with skin lipid membranes","volume":"128","author":"Mistry","year":"2024","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejpb.2025.114798_b0255","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.1039\/D0RA01692F","article-title":"Molecular mechanism of the skin permeation enhancing effect of ethanol: a molecular dynamics study","volume":"10","author":"Gupta","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2025.114798_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122818","article-title":"Improved topical drug delivery: role of permeation enhancers and advanced approaches","volume":"14","author":"Hmingthansanga","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114798_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/nano11123441","article-title":"Ink formulation and printing parameters for inkjet printing of two dimensional materials: a mini review","volume":"11","author":"Jun","year":"2021","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.ejpb.2025.114798_b0270","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-matsci-070909-104502","article-title":"Inkjet printing of functional and structural materials: fluid property requirements, feature stability, and resolution","volume":"40","author":"Derby","year":"2010","journal-title":"Annu. Rev. Mat. Res."},{"key":"10.1016\/j.ejpb.2025.114798_b0275","article-title":"Inkjet printing quality improvement research progress: a review","volume":"10","author":"Cao","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejpb.2025.114798_b0280","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/10407780701348273","article-title":"Liquid ejection characteristics of piezoelectric inkjet printhead for varied work liquids","volume":"52","author":"Cheng","year":"2007","journal-title":"Numer. Heat Transf. A Appl."},{"key":"10.1016\/j.ejpb.2025.114798_b0285","unstructured":"Information, N.C.f.B. PubChem Compound Summary for CID 5757, Estradiol, 2024."},{"key":"10.1016\/j.ejpb.2025.114798_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.112599","article-title":"Measurement and correlation of the solubility of estradiol and estradiol-urea co-crystal in fourteen pure solvents at temperatures from 273.15K to 318.15K","volume":"304","author":"Ning","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2025.114798_b0295","unstructured":"Information, N.C.f.B. PubChem Compound Summary for CID 1030, Propylene Glycol, 2024."},{"key":"10.1016\/j.ejpb.2025.114798_b0300","unstructured":"Information, N.C.f.B. PubChem Compound Summary for CID 702, Ethanol, 2024."},{"key":"10.1016\/j.ejpb.2025.114798_b0305","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/jps.2600740410","article-title":"Solubilization by cosolvents I: Organic solutes in propylene glycol\u2013water mixtures","volume":"74","author":"Yalkowsky","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114798_b0310","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114798_b0315","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0378-5173(02)00334-4","article-title":"Solubilization by cosolvents. establishing useful constants for the log-linear model","volume":"245","author":"Millard","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114798_b0320","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00042192-200007050-00010","article-title":"The effect of site of application on the transcutaneous absorption of 17-beta estradiol from a transdermal delivery system (Climara)","volume":"7","author":"Taggart","year":"2000","journal-title":"Menopause"},{"key":"10.1016\/j.ejpb.2025.114798_b0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/2042018817746291","article-title":"Current best practice in the management of Turner syndrome","volume":"9","author":"Shankar","year":"2018","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.ejpb.2025.114798_b0330","first-page":"4095","article-title":"Diurnal rhythm of 17 beta-estradiol secretion throughout pubertal development in healthy girls: evaluation by a sensitive radioimmunoassay","volume":"81","author":"Norjavaara","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejpb.2025.114798_b0335","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/cen.14578","article-title":"Interpretation of reproductive hormones before, during and after the pubertal transition\u2014identifying health and disordered puberty","volume":"95","author":"Howard","year":"2021","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ejpb.2025.114798_b0340","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020152","article-title":"Alternatives to biological skin in permeation studies: current trends and possibilities","volume":"12","author":"Neupane","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114798_b0345","first-page":"163","article-title":"Skin models for the testing of transdermal drugs","volume":"8","author":"Abd","year":"2016","journal-title":"Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114798_b0350","unstructured":"PubChem. PubChem Compound Summary for CID 5757, Estradiol. Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Estradiol (Accessed on 4th June)."},{"key":"10.1016\/j.ejpb.2025.114798_b0355","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2165\/00003088-200645060-00001","article-title":"Transdermal scopolamine for prevention of motion sickness: clinical pharmacokinetics and therapeutic applications","volume":"45","author":"Nachum","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2025.114798_b0360","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1524-6175.2005.04133.x","article-title":"Transdermal clonidine: therapeutic considerations","volume":"7","author":"Sica","year":"2005","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.ejpb.2025.114798_b0365","first-page":"43","article-title":"Plasma concentrations following application of whole versus cut transdermal clonidine patches to critically Ill children","volume":"9","author":"Zuppa","year":"2004","journal-title":"J. Pediat. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejpb.2025.114798_b0370","article-title":"\u201cI am in pain!\u201d-a case report of illicit use of transdermal fentanyl patches","volume":"13","author":"Guan","year":"2011","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.ejpb.2025.114798_b0375","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40263-019-00637-z","article-title":"Buprenorphine treatment for opioid use disorder: an overview","volume":"33","author":"Shulman","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejpb.2025.114798_b0380","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1021\/acs.molpharmaceut.4c00211","article-title":"Transdermal Drug delivery Systems (TDDS): recent advances and failure Modes","volume":"21","author":"Ghaferi","year":"2024","journal-title":"Mol. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T15:13:52Z","timestamp":1753974832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125001754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":76,"alternative-id":["S0939641125001754"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114798","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inkjet printing of pharmaceutical tattoos for the direct deposition of oestradiol onto skin in turner syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114798"}}